Early-Stage BC Cohort with Vaccination Ipsilateral to Tumor
| Characteristic | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 |
|---|---|---|---|---|---|---|---|
| Demographic | |||||||
| Age (y) | 45 | 52 | 38 | 81 | 48 | 76 | 66 |
| Breast tumor | Left | Left | Left | Left | Left | Right | Right |
| Vaccination | |||||||
| Injection side (deltoid) | Left | Left | Left | Left | Left | Right | Right |
| Type | mRNA | mRNA | mRNA | mRNA | Viral vector | Viral vector | mRNA |
| Number of doses | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
| 18F-FDG PET/CT imaging | |||||||
| Interval* (d) | 7 | 3 | 11 | 22 | 32 | 6 | 17 |
| HLN location | Left axilla | Left axilla | Left axilla | Left axilla | Left axilla | Right axilla | Right axilla |
| LN SUVmax | 7.9 | 2.0 | 3.2 | 4.3 | 3.7 | 3.4 | 4.3 |
| LN size (small axis in mm) | 11 | 7 | 8 | 6 | 8 | 6 | 12 |
| Number of HLNs | >5 | >5 | >5 | 4 | 2 | 4 | >5 |
| Peripheral blood | |||||||
| ALC (×109/L) | 1.92 | Unknown | 2.35 | 1.70 | 0.84 | Unknown | 2.32 |
| Lymphopenia | No | Unknown | No | No | Yes | Unknown | No |
| Histology modality | Cytology | Cytology | Sentinel LN | Sentinel LN | Sentinel LN | None | Cytology |
| Etiology | Tumor | Tumor | Vaccine | Vaccine | Vaccine | Unknown | Tumor |
* Between last dose and PET.
LN = lymph nodes.